Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the ...

TRIM28 is an integrant part of the larger-scale chromatin architecture that characterises the activated functional state but dispensable for CD8 T cell maturation.

The following is a summary of “Role of T cell metabolism in brain tumor development: a genetic and metabolic approach,” ...

Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live longer and better destroy cancer cells in a mouse model of melanoma compared ...

Researchers have developed a new method for growing T cells in the lab, allowing them to survive longer and fight cancer more effectively. This advancement, detailed in Cell Metabolism, could ...

Armed with $120 million and a clinical-stage asset, another player is emerging in the increasingly crowded T cell engager ... which targets B-cell maturation antigen (BCMA).

Helmed by biotech veteran Ken Song, M.D., Candid burst onto the scene in September 2024 equipped with a $370 million series A and T-cell engagers targeting B-cell maturation antigen and CD20 that ...

Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.

So B-cell maturation antigen is an evolving ... We also have developments on how we target or do CAR T-cell therapy. So there are development in using GBRC5D target for CAR T-cell therapy and ...

TRIM28 is an integrant part of the larger-scale chromatin architecture that characterises the activated functional state but dispensable for CD8 T cell maturation. Comparing T cells in nasal ...